Cargando…
Population pharmacokinetic–pharmacodynamic modelling in oncology: a tool for predicting clinical response
In oncology trials, overall survival (OS) is considered the most reliable and preferred endpoint to evaluate the benefit of drug treatment. Other relevant variables are also collected from patients for a given drug and its indication, and it is important to characterize the dynamic effects and links...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Science Inc
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294077/ https://www.ncbi.nlm.nih.gov/pubmed/24134068 http://dx.doi.org/10.1111/bcp.12258 |